Catalyst Wire Dossier Catalyst Wire Dossier

TRV130 (oliceridine)

oliceridine · Trevena Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TRV130 (oliceridine), covering 2015-11-18 to 2017-05-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals [Phase 1]

See pricing